Details

Autor(en) / Beteiligte

• Chrétien, B.
• Dolladille, C.
• Alexandre, J.
• Fedrizzi, S.
• Lelong‐Boulouard, V.
• Lambert, J.C.
• Ezine, E.

Titel

Dupilumab‐associated arthralgia: an observational retrospective study in VigiBase

Ist Teil von

• British journal of dermatology (1951), 2021-08, Vol.185 (2), p.464-465

Ort / Verlag

England: Blackwell Publishing Ltd

Erscheinungsjahr

2021

Link zum Volltext

Quelle

Wiley Online Library Journals Frontfile Complete

Beschreibungen/Notizen

• Dear Editor, Dupilumab is a human monoclonal antibody that blocks the shared receptor unit for interleukin (IL)-4 and IL-13, and is approved in several indications, including moderate-to-severe atopic dermatitis (AD). According to a recent meta-analysis dupilumab treatment versus placebo resulted in a significant increase in the number of patients who achieved Eczema Area and Severity Index-75 (Rate-Ratio 3.09; 95% CI 2.45-3.89) in different ethnical populations.